Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy

Freek W.A. Verheugt; Peter Clemmensen; Roxana Mehran; Stefan Agewall; Stuart J. Pocock; Sidney Goldstein; Christian Torp-Pedersen; Maarten L. Simoons; Jeffrey S. Borer; Yasser M. Khder; Paul Burton; Efthymios Deliargyris; John J.V. McMurray; Scott D. Berkowitz; Wendy Gattis Stough; Faiez Zannad

doi:10.1093/eurheartj/eht013

Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy

Freek W.A. Verheugt
, Peter Clemmensen
, Roxana Mehran
, Stefan Agewall
, Stuart J. Pocock
, Sidney Goldstein
, Christian Torp-Pedersen
, Maarten L. Simoons
, Jeffrey S. Borer
, Yasser M. Khder
, Paul Burton
, Efthymios Deliargyris
, John J.V. McMurray
, Scott D. Berkowitz
, Wendy Gattis Stough
, Faiez Zannad

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	1621-1629
Number of pages	9
Journal	European Heart Journal
Volume	34
Issue number	22
DOIs	https://doi.org/10.1093/eurheartj/eht013
State	Published - 7 Jun 2013

Access to Document

10.1093/eurheartj/eht013

Cite this

Verheugt, F. W. A., Clemmensen, P., Mehran, R., Agewall, S., Pocock, S. J., Goldstein, S., Torp-Pedersen, C., Simoons, M. L., Borer, J. S., Khder, Y. M., Burton, P., Deliargyris, E., McMurray, J. J. V., Berkowitz, S. D., Stough, W. G., & Zannad, F. (2013). Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy. European Heart Journal, 34(22), 1621-1629. https://doi.org/10.1093/eurheartj/eht013

@article{043b5b3b4af9464d95084221fb67a456,

title = "Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy",

author = "Verheugt, \{Freek W.A.\} and Peter Clemmensen and Roxana Mehran and Stefan Agewall and Pocock, \{Stuart J.\} and Sidney Goldstein and Christian Torp-Pedersen and Simoons, \{Maarten L.\} and Borer, \{Jeffrey S.\} and Khder, \{Yasser M.\} and Paul Burton and Efthymios Deliargyris and McMurray, \{John J.V.\} and Berkowitz, \{Scott D.\} and Stough, \{Wendy Gattis\} and Faiez Zannad",

note = "Funding Information: This work was generated from discussions during the 7th and 8th Global Cardiovascular Clinical Trialists (CVCT) Forums held in Paris, France, in December 2010 and 2011. CVCT was organized by the Clinical Investigation Center (CIC) Inserm, CHU, and University Henri Poincar{\'e} of Nancy, France and funded by an unrestricted educational grant from Association de Recherche et d{\textquoteright}Information en Cardiologie (ARISC) a non-profit educational organisation, in Nancy, France. ARISC had no involvement in preparation, review, or approval of the manuscript for publication.",

year = "2013",

month = jun,

day = "7",

doi = "10.1093/eurheartj/eht013",

language = "English",

volume = "34",

pages = "1621--1629",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "22",

}

Verheugt, FWA, Clemmensen, P, Mehran, R, Agewall, S, Pocock, SJ, Goldstein, S, Torp-Pedersen, C, Simoons, ML, Borer, JS, Khder, YM, Burton, P, Deliargyris, E, McMurray, JJV, Berkowitz, SD, Stough, WG & Zannad, F 2013, 'Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy', European Heart Journal, vol. 34, no. 22, pp. 1621-1629. https://doi.org/10.1093/eurheartj/eht013

TY - JOUR

T1 - Antithrombotic outcome trials in acute coronary syndromes

T2 - Seeking the optimal balance between safety and efficacy

AU - Verheugt, Freek W.A.

AU - Clemmensen, Peter

AU - Mehran, Roxana

AU - Agewall, Stefan

AU - Pocock, Stuart J.

AU - Goldstein, Sidney

AU - Torp-Pedersen, Christian

AU - Simoons, Maarten L.

AU - Borer, Jeffrey S.

AU - Khder, Yasser M.

AU - Burton, Paul

AU - Deliargyris, Efthymios

AU - McMurray, John J.V.

AU - Berkowitz, Scott D.

AU - Stough, Wendy Gattis

AU - Zannad, Faiez

N1 - Funding Information: This work was generated from discussions during the 7th and 8th Global Cardiovascular Clinical Trialists (CVCT) Forums held in Paris, France, in December 2010 and 2011. CVCT was organized by the Clinical Investigation Center (CIC) Inserm, CHU, and University Henri Poincaré of Nancy, France and funded by an unrestricted educational grant from Association de Recherche et d’Information en Cardiologie (ARISC) a non-profit educational organisation, in Nancy, France. ARISC had no involvement in preparation, review, or approval of the manuscript for publication.

PY - 2013/6/7

Y1 - 2013/6/7

UR - https://www.scopus.com/pages/publications/84878853362

U2 - 10.1093/eurheartj/eht013

DO - 10.1093/eurheartj/eht013

M3 - Article

C2 - 23382466

AN - SCOPUS:84878853362

SN - 0195-668X

VL - 34

SP - 1621

EP - 1629

JO - European Heart Journal

JF - European Heart Journal

IS - 22

ER -